Profitability Metrics

Gross Margin
66.83%
Operating Margin
11.41%
Net Margin
9.75%

Efficiency Metrics

Revenue per Expense Ratio
1.13
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
16.00%
Income Tax Rate
16.86%
EPS
9.9100000000

Balance Sheet Analysis

Current Ratio
2.29
Cash Ratio
1.22
Working Capital
$1.89B
Debt to Equity
1.09
Debt to Assets
40.52%
Equity Ratio
37.11%

Cash Flow Analysis

Operating Cash Flow Ratio
16.13%
Free Cash Flow Ratio
13.65%
CapEx to Revenue
2.49%
Dividends Paid
$194.60M
Stock Buybacks
$449.70M
Total Shareholder Returns
$644.30M
Cash Position Change
8.77%

Key Takeaways (2024 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 1.90%

Detailed Growth Metrics

Core Performance

Revenue
2.91%
Net Income
23.65%
EPS
28.37%
Operating Income
7.41%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
5.44%
Operating Cash Flow
160.27%
Free Cash Flow
367.65%

Balance Sheet Health

Assets
-2.75%
Debt
-6.51%
Book Value per Share
4.68%
Inventory
-15.78%

Shareholder Returns

Dividends per Share
1.90%
Shares Outstanding
-3.69%

Long Term Trends

3Y Revenue/Share
69.87%
5Y Revenue/Share
29.85%
3Y Dividend/Share
340.51%
5Y Dividend/Share
26.15%